VHL vitasora health limited

phase 3 studies for tg4010, page-4

  1. 5,884 Posts.
    lightbulb Created with Sketch. 1774
    Absolutely agree.


    Transgene seem very confident about the future of TG4010 and that is reinforced by there €10 million joint venture commitment to the development plant in Lyon.

    Again I agree that they may have another suitor in the wings. Hence the standard of subscription contributors identified in the share issue.

    It bodes well that they have in place a strong and financially backed plan B.

    So im happy to watch from the wings as these and other developments unfold.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.5¢
Change
-0.001(3.85%)
Mkt cap ! $42.96M
Open High Low Value Volume
2.4¢ 2.5¢ 2.4¢ $32.15K 1.286M

Buyers (Bids)

No. Vol. Price($)
1 1803 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 600783 5
View Market Depth
Last trade - 12.30pm 07/08/2025 (20 minute delay) ?
VHL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.